Alexander Morokutti

A Novel Type of Influenza Vaccine: Safety and Immunogenicity of Replication‐Deficient Influenza Virus Created by Deletion of the Interferon Antagonist NS1

Volker Wacheck, Andrej Egorov, Franz Groiss et al. · The Journal of Infectious Diseases · 2009 · 130 citations

Vaccination, Vaccine Safety, Adverse Events +13

Single HA2 Mutation Increases the Infectivity and Immunogenicity of a Live Attenuated H5N1 Intranasal Influenza Vaccine Candidate Lacking NS1

Brigitte M. Krenn, Andrej Egorov, Ekaterina Romanovskaya-Romanko et al. · PLoS ONE · 2011 · 83 citations · Full text

Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine

Julia Romanova, Brigitte M. Krenn, Markus Wolschek et al. · PLoS ONE · 2009 · 72 citations · Full text

Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1

Sabine Nakowitsch, Markus Wolschek, Alexander Morokutti et al. · Vaccine · 2011 · 40 citations

Vaccination, Vaccine Development, Immunology +8

Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans

Alexander Morokutti, Thomas Muster, Boris Ferko · Vaccine · 2014 · 39 citations

Vaccination, Mucosal Vaccination, Vaccine Development +8